PRLD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Prelude Therapeutics Inc

Watchlist Manager

Watchlist

Price: 6.34 USD -3.35% Market Closed

Market Cap: $505m

	Prelude Therapeutics Inc NASDAQ:PRLD	US
	LifeVantage Corp NASDAQ:LFVN	US
	StageZero Life Sciences Ltd TSX:SZLS	CA
	Pabrik Kertas Tjiwi Kimia Tbk PT F:OB9	ID
	Marathon Petroleum Corp NYSE:MPC	US
S	Somboon Advance Technology PCL SET:SAT	TH
	MoneyLion Inc NYSE:ML	CN
	Bulletin Resources Ltd ASX:BNR	AU
	Sodexo SA PAR:SW	FR
P	Priya Ltd BSE:524580	IN
	United Malt Group Ltd ASX:UMG	AU
H	Hisense Home Appliances Group Co Ltd HKEX:921	CN
A	AEE Gold AG DUS:AEE1	DE
P	Pomvom Ltd TASE:PMVM	IL

Profitability Summary

Prelude Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-301%

Negative 3Y Average Operating Margin

-1 460%

Negative Net Margin

-270%

Negative 3Y Average Net Margin

-1 338%

Negative Free Cash Flow Margin

-148%

Negative 3Y Average Free Cash Flow Margin

-1 149%

Negative ROE

-58%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-393%

ROIC is Increasing

-942% > -186%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.